The government is correcting a customer list for the specialty pharmacy at the center of a national fungal meningitis outbreak.

Some 14 Maine companies were on the list.

The Food and Drug Administration on Monday listed the medical practices in each state that received any products since May that were later recalled, and how much each received.

A note posted to the announcement Tuesday reported that the FDA found “problems with the list” and some information was incorrect. The agency reported that it was working to correct the list and would post it when the agency was sure it was accurate.

The listed companies were all customers of New England Compounding Center of Framingham, Mass.

A deadly outbreak of a rare fungal form of meningitis has been tied to steroid shots made by the company since May.

Last month, the company recalled the steroid shots that went to clinics in 23 states.

That recall was later expanded to all its products, and the lists show they went to a longer list of states.

More information can be found on the FDA’s website, www.fda.gov.

Augusta and Waterville news

Get news and events from your towns in your inbox every Friday.


  • This field is for validation purposes and should be left unchanged.